相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Convalescent plasma therapy in patients with COVID-19
Fevzi Altuntas et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
Early mortality benefit with COVID-19 convalescent plasma: a matched control study
Aarthi G. Shenoy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome *
Abolghasem Allahyari et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients
Marc Klapholz et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
A matched cohort study of convalescent plasma therapy for COVID-19
Oleg V. Sostin et al.
JOURNAL OF CLINICAL APHERESIS (2021)
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
Maria Elvira Balcells et al.
PLOS MEDICINE (2021)
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
Michele L. Donato et al.
JCI INSIGHT (2021)
Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
Pedro Kurtz et al.
FRONTIERS IN MEDICINE (2021)
Effectiveness of convalescent plasma in Indian patients with COVID-19
Sandeep Budhiraja et al.
BLOOD CELLS MOLECULES AND DISEASES (2021)
Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients - propensity-score matched case-control study
Adam Tworek et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia
Nawal AlShehry et al.
SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES (2021)
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Lopes et al.
RMD OPEN (2021)
The 2020 race towards SARS-CoV-2 specific vaccines
Tomasz M. Karpinski et al.
THERANOSTICS (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas et al.
AUTOIMMUNITY REVIEWS (2020)
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Gian Battista Danzi et al.
EUROPEAN HEART JOURNAL (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Matt Arentz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
Mingxiang Ye et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma A proof-of-concept, single-arm, multicenter trial .
Cesare Perotti et al.
HAEMATOLOGICA (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Lessons learned from early compassionate use of convalescent plasma on critically ill patients withCovid-19
Miao Liu et al.
TRANSFUSION (2020)
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
Hassan Abolghasemi et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report
Italo Cantore et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
Evangelos Terpos et al.
MICROORGANISMS (2020)
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
Theodora Psaltopoulou et al.
HEMASPHERE (2020)
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Prasun K. Datta et al.
THERANOSTICS (2020)
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Gian Battista Danzi et al.
EUROPEAN HEART JOURNAL (2020)
Viral-Induced Enhanced Disease Illness
Maria K. Smatti et al.
FRONTIERS IN MICROBIOLOGY (2018)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Fc receptors in antibody-dependent enhancement of viral infections
Adam Taylor et al.
IMMUNOLOGICAL REVIEWS (2015)
The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation
Alan E. Jones et al.
CRITICAL CARE MEDICINE (2009)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Treatment of severe acute respiratory syndrome
ST Lai
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
YOY Soo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)